Poland· PL-100416513

Luxturna

A voretigene neparvovec product containing voretigenum neparvovecum, registered in Poland by Novartis Europharm Limited. The same ATC class is registered in 13 of our 19 countries.

ATC S01XA27

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedLuxturnaATCS01XA27REGISTER NO.PL-100416513PACKS LISTED5CHECKEDSeptember 27, 2026

Where it is registered

Voretigene neparvovec is registered in 13 of 19 countries.

Countries holding a registration under ATC S01XA27 (voretigene neparvovec), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose

Voretigene neparvovec · ATC S01XA27

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Voretigenum neparvovecum
Manufacturer
Novartis Europharm Limited
Country
Poland (PL)
ATC code
S01XA27
ATC class
Voretigene neparvovec
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 5

  • gtin
    07613421040529
  • gtin
    03400955060796
  • gtin
    04150152053112
  • gtin
    07613421025205
  • gtin
    07612797522080

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f2de54ee-4db9-4065-9f9c-9fbc8cc21daf
GET /v1/drugs/f2de54ee-4db9-4065-9f9c-9fbc8cc21daf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Koncentrat i rozpuszczalnik do sporządzania roztworu do wstrzykiwań",
  "source": "urpl",
  "strength": "5 x 10^12 genomów wektora/ml",
  "packaging": "07613421040529 ¦ Rpz ¦ EU/1/18/1331/001 ¦ 131287\n1 fiol. 0,5 ml koncentratu ¦ 2 fiol. 1,7 ml rozpuszczalnika\n¦ UR/Z/4b/026/23 - 03400955060796, 04150152053112, 07613421025205 ¦ UR/Z/4b/221/24 - 04150152053112",
  "substance": "Voretigenum neparvovecum 5 x 10^12 genomów wektora/ml",
  "common_name": "Voretigenum neparvovecum",
  "pl_product_id": "100416513",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}

See everything about voretigene neparvovec.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.